Metabolic Pathway Research · GLP-1 / GLP-2 receptor agonist
DapiglutideDual GLP-1 and GLP-2 receptor agonist.
A metabolic peptide candidate in the next-generation incretin category.
0 papers·Clinical development / paused or deprioritized in some pipelines·COA Unverified·0 saved
Vendors
0 vendors / 0 options$0.00–$0.00/mg
| Vendor | Tier | Products / options | Salt | Purity | COA | $/mg |
|---|
Reference
Regulatory Status
USResearch only
EUNot approved
UKResearch only
AUResearch only
Regulatory status may change. Always verify current regulations in your jurisdiction before purchase.